Market Overview

A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Initial Jobless Claims, Producer Prices Data

Share:
A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Initial Jobless Claims, Producer Prices Data

Pre-open movers

U.S. stock futures traded higher in early pre-market trade. Data on initial jobless claims for the latest week and the Producer Price Index for November will be released at 8:30 a.m. ET.

Futures for the Dow Jones Industrial Average gained 22 points to 27,946 while the Standard & Poor’s 500 index futures traded rose 3.15 points to 3,146.25. Futures for the Nasdaq 100 index gained 11.75 points to 8,417.25.

Oil prices traded higher as Brent crude futures rose 0.8% to trade at $64.20 per barrel, while US WTI crude futures rose 0.5% to trade at $59.04 a barrel. The Energy Information Administration’s weekly report on natural gas stocks in underground storage is schedule for release at 10:30 a.m. ET.

A Peek Into Global Markets

European markets were higher today, with the Spanish Ibex Index rising 0.1%, STOXX Europe 600 Index gaining 0.1% and German DAX 30 index gaining 0.2%. The UK's FTSE index was trading higher by 0.5%, while French CAC 40 Index rose 0.1%.

In Asian markets, Japan’s Nikkei Stock Average rose 0.14%, Hong Kong’s Hang Seng Index gained 1.31%, China’s Shanghai Composite Index fell 0.3% and India’s BSE Sensex rose 0.42%.

Broker Recommendation

Analysts at JP Morgan upgraded Starbucks Corporation (NASDAQ: SBUX) from Neutral to Overweight and raised the price target from $90 to $94.

Starbucks shares rose 1.8% to $88.18 in pre-market trading.

Breaking News

  • Lululemon Athletica Inc (NASDAQ: LULU) reported better-than-expected earnings for its third quarter, but issued soft earnings guidance for the fourth quarter.
  • Assembly Biosciences Inc (NASDAQ: ASMB) priced its 5.15 million common shares at $16.50 per share.
  • Miragen Therapeutics Inc (NASDAQ: MGEN) announced strategic changes. It will reduce its workforce by 18 employees.
  • Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) announced a new European patent for composition and formulation of TNX-102 SL. The patent will provide the company with market exclusivity until 2034.

Posted-In: A Peek Into The MarketsEarnings News Eurozone Futures Global Pre-Market Outlook Markets

 

Related Articles (LULU + ASMB)

View Comments and Join the Discussion!
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com